ConductScience.org, home

Paper359390

The effect of E. coli L-asparaginase on oral glucose tolerance and insulin release in man.

Lavine RL and 3 others. Diabetologia, 1978. Cited by 16 papers, by iCite.

Cite this record

ConductScience Library. The effect of E. coli L-asparaginase on oral glucose tolerance and insulin release in man. Papers, record 359390. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/359390

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The effect of E. coli L-asparaginase on oral glucose tolerance and insulin release in man.
PubMed
Journal
Diabetologia
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
16
iCite
Relative citation ratio, by iCite
0.46
iCite
Revised in PubMed
2019-08-16
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lavine RLR L
2Brodsky II
3Garofano CDC D
4Rose LIL I

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AsparaginaseMajor topic
Escherichia coliMajor topic
Glucose Tolerance TestMajor topic
InsulinMajor topic
Adult
Aged
Female
Humans
Male
Middle Aged
Neoplasms

Source PubMed

Download CSV of topics

References18

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
15034858Transient diabetes mellitus secondary to L-asparaginase therapy in acute leukemia.J Pediatr1972https://conductscience.org/library/papers/5034858PubMed
24168535Glucose tolerance and diabetes in chronic liver disease.Lancet1967https://conductscience.org/library/papers/4168535PubMed
35468791Solid-phase radioimmunoassay of insulin.Acta Endocrinol (Copenh)1970https://conductscience.org/library/papers/5468791PubMed
44634039Nonketotic hyperglycemia due to prednisone (NSC-10023) following ketotic hyperglycemia due to L-asparaginase (NSC-109229) plus prednisone.Cancer Chemother Rep1972https://conductscience.org/library/papers/4634039PubMed
54785429Effect of transient elevation of plasma insulin within physiologic levels (simulated early insulin response) on blood glucose.J Clin Endocrinol Metab1973https://conductscience.org/library/papers/4785429PubMed
6320877Glucose and lactate kinetics after endotoxin administration in dogs.Am J Physiol1977https://conductscience.org/library/papers/320877PubMed
75775719L-asparaginase toxicity.Cancer Res1969https://conductscience.org/library/papers/5775719PubMed
85284834Diabetes in patients treated with asparaginase.Clin Pharmacol Ther1971https://conductscience.org/library/papers/5284834PubMed
94936881Relationship between intravenous glucose loads, insulin responses and glucose disappearance rate.J Clin Endocrinol Metab1971https://conductscience.org/library/papers/4936881PubMed
104906449L-asparaginase.N Engl J Med1970https://conductscience.org/library/papers/4906449PubMed
124913910Effect of L-asparaginase on carbohydrate metabolism.Metabolism1970https://conductscience.org/library/papers/4913910PubMed
135280988Fibrinogen survival with [75Se]Selenomethionine during L-asparaginase therapy.Br J Haematol1971https://conductscience.org/library/papers/5280988PubMed
144906595Hypoglycemia of shock.Ann Surg1970https://conductscience.org/library/papers/4906595PubMed
154913953L-asparaginase.Annu Rev Med1970https://conductscience.org/library/papers/4913953PubMed
164920133Biochemical and pharmacological studies with asparaginase in man.Cancer Res1970https://conductscience.org/library/papers/4920133PubMed
175082588Effects of L-asparaginase on lymphocyte surface and blastogenesis.Cancer Res1972https://conductscience.org/library/papers/5082588PubMed
186061732The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects.J Clin Invest1967https://conductscience.org/library/papers/6061732PubMed
194626307Toxicity of L-asparginase in children with advanced leukemia.Cancer1972https://conductscience.org/library/papers/4626307PubMed

Download CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.

PMIDTitleJournalYearIn PapersSource
39766036Acute Myeloid Leukaemia and Acute Lymphoblastic Leukaemia Classification and Metabolic Characteristics for Informing and Advancing Treatment.Cancers (Basel)2024https://conductscience.org/library/papers/39766036PubMed
18923438Clinical consequences of hyperglycemia during remission induction therapy for pediatric acute lymphoblastic leukemia.Leukemia2009https://conductscience.org/library/papers/18923438PubMed
6167443Transient secondary hypothyroidism and thyroxine binding globulin deficiency in leukemic children during polychemotherapy: an effect of L-asparaginase.Eur J Pediatr1981https://conductscience.org/library/papers/6167443PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
INS3630PubTator's text mininghttps://conductscience.org/library/genes/3630

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/359390

GET https://conductscience.org/api/papers/v1/359390/authors